Biocept reported $35.96M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Arena Pharmaceuticals ARNA:US $ 990.44M 131.17M
Becton, Dickinson and BDX:US $ 9538M 462M
Biocept BIOC:US $ 35.96M 0.66M
Celldex Therapeutics CLDX:US $ 167.61M 13.89M
Cerulean Pharma CERU:US $ 14.06M 4.46M
Cytori Therapeutics CYTX:US $ 18M 2.55M
General Electric GE:US 102.41B 10.79B
Illumina ILMN:US $ 5310M 332M
Quest Diagnostics DGX:US $ 2146M 853M
Thermo Fisher Scientific TMO:US $ 19260M 1575M